期刊文献+

Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best? 被引量:2

Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best?
下载PDF
导出
摘要 AIM: To compare the ability of model for end-stage liver disease(MELD)-Na and Maddrey discrimination function index(DFI) to predict mortality at 30 and 90 d in patients with alcoholic hepatitis(AH).METHODS: We prospectively assessed 52 patients with AH. Demographic, clinical and laboratory parameters were obtained. MELD-Na and Maddrey DFI were calculated on admission. Short-term mortality was assessed at 30 and 90 d. Receiver operating characteristic curve analysis was performed. RESULTS: Thirty-day and 90-d mortality was 44% and 58%, respectively. In the univariate analysis, sodium levels was associated with mortality at 30 and 90 d(P = 0.001 and P = 0.03). Child stage, encephalopathy, ascites, or types of treatment were not associated with mortality. MELD-Na was the only predictive factor for mortality at 90 d. For 30-d mortality area under the curve(AUC) was 0.763(95%CI: 0.63-0.89) for Maddrey DFI and 0.784 for MELD-Na(95%CI: 0.65-0.91, P = 0.82). For 90-d mortality AUC was 0.685(95%CI: 0.54-0.83) for Maddrey DFI and 0.8710 for MELD-Na(95%CI: 0.76-0.97, P = 0.041). CONCLUSION: AH is associated with high shortterm mortality. Our results show that MELD-Na is a more valuable model than DFI to predict short-term mortality. AIM To compare the ability of model for end-stageliver disease (MELD)-Na and Maddrey discriminationfunction index (DFI) to predict mortality at 30 and 90 din patients with alcoholic hepatitis (AH).METHODS: We prospectively assessed 52 patientswith AH. Demographic, clinical and laboratory parameterswere obtained. MELD-Na and Maddrey DFI werecalculated on admission. Short-term mortality wasassessed at 30 and 90 d. Receiver operating characteristiccurve analysis was performed.RESULTS: Thirty-day and 90-d mortality was 44% and58%, respectively. In the univariate analysis, sodiumlevels was associated with mortality at 30 and 90 d (P= 0.001 and P = 0.03). Child stage, encephalopathy,ascites, or types of treatment were not associatedwith mortality. MELD-Na was the only predictivefactor for mortality at 90 d. For 30-d mortality area under the curve (AUC) was 0.763 (95%CI: 0.63-0.89)for Maddrey DFI and 0.784 for MELD-Na (95%CI:0.65-0.91, P = 0.82). For 90-d mortality AUC was 0.685(95%CI: 0.54-0.83) for Maddrey DFI and 0.8710 forMELD-Na (95%CI: 0.76-0.97, P = 0.041).CONCLUSION: AH is associated with high shorttermmortality. Our results show that MELD-Na is amore valuable model than DFI to predict short-termmortality.
出处 《World Journal of Hepatology》 CAS 2015年第17期2119-2126,共8页 世界肝病学杂志(英文版)(电子版)
关键词 ALCOHOLIC HEPATITIS Model for end-stageliver disease-Na Maddrey Mortality Alcoholic hepatitis Model for end-stage liver disease-Na Maddrey Mortality
  • 相关文献

参考文献40

  • 1Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, SoddeM, Saveria Crocè L, Sasso F, Pozzato G, Cristianini G, BrandiG. Drinking habits as cofactors of risk for alcohol induced liverdamage. The Dionysos Study Group. Gut 1997; 41: 845-850 [PMID:9462221].
  • 2Becker U, Deis A, S-rensen TI, Gr-nbaek M, Borch-Johnsen K,Müller CF, Schnohr P, Jensen G. Prediction of risk of liver diseaseby alcohol intake, sex, and age: a prospective population study.Hepatology 1996; 23: 1025-1029 [PMID: 8621128 DOI: 10.1002/hep.510230513].
  • 3Altamirano J, Higuera-de laTijera F, Duarte-Rojo A, Martínez-Vázquez MA, Abraldes JG, Herrera-Jiménez LE, Michelena J,Zapata L, Perez-Hernández J, Torre A, Gonzáles-González JA,Cardenas A, Dominguez M, Arroyo V, Ginès P, Caballería J,Bataller R. The amount of alcohol consumption negatively impactsshort-term mortality in Mexican patients with alcoholic hepatitis.Am J Gastroenterol 2011; 106: 1472-1480 [PMID: 21556041 DOI:10.1038/ajg.2011.141].
  • 4Choi G, Runyon BA. Alcoholic hepatitis: a clinician's guide. ClinLiver Dis 2012; 16: 371-385 [PMID: 22541704 DOI: 10.1016/j.cld.2012.03.015].
  • 5Singal AK, Shah VH. Alcoholic hepatitis: prognostic models andtreatment. Gastroenterol Clin North Am 2011; 40: 611-639 [PMID:21893277 DOI: 10.1016/j.gtc.2011.06.008].
  • 6Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N EnglJ Med 2009; 360: 2758-2769 [PMID: 19553649 DOI: 10.1056/nejmra0805786].
  • 7Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, WhiteRI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology1978; 75: 193-199 [PMID: 352788].
  • 8Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoyNC, Fisher NC, Singhal S, Brind A, Haydon G, O'Grady J, Day CP,Hayes PC, Murray LS, Morris AJ. Analysis of factors predictive ofmortality in alcoholic hepatitis and derivation and validation of theGlasgow alcoholic hepatitis score. Gut 2005; 54: 1174-1179 [PMID:16009691].
  • 9Dominguez M, Rincón D, Abraldes JG, Miquel R, Colmenero J,Bellot P, García-Pagán JC, Fernández R, Moreno M, Ba-ares R,Arroyo V, Caballería J, Ginès P, Bataller R. A new scoring systemfor prognostic stratification of patients with alcoholic hepatitis. AmJ Gastroenterol 2008; 103: 2747-2756 [PMID: 18721242 DOI:10.1111/j.1572-0241.2008.02104.x].
  • 10Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, FartouxL, Dharancy S, Texier F, Hollebecque A, Serfaty L, BoleslawskiE, Deltenre P, Canva V, Pruvot FR, Mathurin P. The Lille model: anew tool for therapeutic strategy in patients with severe alcoholichepatitis treated with steroids. Hepatology 2007; 45: 1348-1354[PMID: 17518367 DOI: 10.1002/hep.21607].

同被引文献4

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部